Ovid Therapeutics
OVID
#9134
Rank
โ‚น10.42 B
Marketcap
โ‚น146.33
Share price
3.18%
Change (1 day)
51.24%
Change (1 year)

Revenue for Ovid Therapeutics (OVID)

Revenue in 2025 (TTM): โ‚น0.56 Billion

According to Ovid Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚น0.60 Billion. In 2024 the company made a revenue of โ‚น48.55 Million an increase over the revenue in the year 2023 that were of โ‚น32.59 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Ovid Therapeutics from 2016 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น0.56 B1073.37%
2024 โ‚น48.55 M48.96%
2023 โ‚น32.59 M-73.79%
2022 โ‚น0.12 B-99.2%
2021 โ‚น15.51 B1580.87%
2020 โ‚น0.92 B
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA